Market Place
Sourcing Support
All News #Library
Biotech
Marengo To Unveil Start-002 Study Results At 2025 Breast Cancer
12 Dec 2025 //
PR NEWSWIRE BIO
Marengo Invikafusp Alfa Shows Pan Tumor Activity In Ph2 Trial
07 Nov 2025 //
PR NEWSWIRE
Marengo To Unveil Invikafusp Alfa Monotherapy Data at SITC 2025
31 Oct 2025 //
PR NEWSWIRE
Marengo’s Ph2 Data Show Invikafusp Alfa Activity at ESMO
17 Oct 2025 //
PR NEWSWIRE
Marengo To Unveil Late-Breaking ESMO 2025 Abstract On Invikafusp
24 Sep 2025 //
PR NEWSWIRE
Marengo Therapeutics Expands STARt-002 Trial to Phase 2
18 Sep 2025 //
PR NEWSWIRE
Marengo Therapeutics Appoints Dr. Dolsten to Board, Dr. Tabernero
31 Jul 2025 //
PR NEWSWIRE
Marengo Highlights Invikafusp in PD-1 Resistant GI Tumors
02 Jul 2025 //
PR NEWSWIRE
Marengo Doses First Patient in Phase 2 Study for Invikafusp Alfa
20 Dec 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.